arrow
A

Anthi Bouchla

National and Kapodistrian University of Athens
H指数:11
被引数:385

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS)

来那度胺在伴del-5q的骨髓增生异常综合征患者中的疗效:来自希腊骨髓增生异常与低增生性综合征登记研究(EAKMYS)的真实世界数据

CANCERS
IF4.4
2025-04-220
OA
Real-World Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Treated with Teclistamab and Talquetamab; A Multicenter Analysis from the Greek Myeloma Study Group

真实世界研究中接受teclistamab和talquetamab治疗的复发/难治性多发性骨髓瘤患者的结局;希腊骨髓瘤研究小组的多中心分析

BLOOD
IF23.1
2024-11-050
PRE
Primary Adrenal Lymphomas with Cushing's Syndrome: Two Cases with Evidence of Endogeneous Cortisol Production by the Neoplastic Lymphoid Cells
2023-07-311
OAAI
Kinetics of Nucleocapsid, Spike and Neutralizing Antibodies, and Viral Load in Patients with Severe COVID-19 Treated with Convalescent Plasma
2021-09-156
OAAI
A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19-A Propensity Score-Matched Control Analysis
2021-04-118
OAAI
Upregulated hypoxia inducible factor 1α signaling pathway in high risk myelodysplastic syndrome and acute myeloid leukemia patients is associated with better response to 5-azacytidine-data from the Hellenic myelodysplastic syndrome study group
2021-01-014
PREAI
Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes
2020-12-0812
OAAI
Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher-risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes
2020-06-262
PREAI
Effectiveness of 5-Azacytidine in older patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia: A retrospective analysis of the Hellenic (Greek) MDS Study Group
2020-01-014
OAAI